Houston Methodist

Engineering in Precision Medicine

Ali Khademhosseini, PhD, Terasaki Institute for Biomedical Innovation, is interested in developing ‘personalized’ solutions that utilize micro-and nanoscale technologies to enable a range of therapies for organ failure, cardiovascular disease and cancer. His group also aims to engineer tissue regenerative therapeutics using water-containing polymer networks called hydrogels that can regulate cell behavior. Specifically, he has developed photo-crosslinkable hybrid hydrogels that combine natural biomolecules with nanoparticles to regulate the chemical, biological, mechanical and electrical properties of gels. It is anticipated that such approaches will lead to the development of next-generation regenerative therapeutics and biomedical devices.

Dial-In Information

Streamed online via WebEx

Please use the link below for the live stream.

https://houstonmethodist.webex.com/houstonmethodist/j.php?MTID=md15c1afe362448d7d456b2c063bcf3cd

Wednesday, July 7 at 1:00pm to 2:00pm

Virtual Event
Event Type

Seminar, Webinar

Attendance Options

Livestream Video

Category

Research

Department & Center
Academic Institute, Department of Nanomedicine
Speaker

Ali Khademhosseini, PhD Chief Executive Officer, Paul I. Terasaki Distinguished Professor, Terasaki Institute for Biomedical Innovation

Contact Email

cmorgan@houstonmethodist.org

Subscribe
Google Calendar iCal Outlook